Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT06033599 · Rutgers, The State University of New Jersey

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

What this study is about

The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.

View original scientific description

The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.

Interventions

OTHER

MORE and MI and NRT

Eight group Mindfulness Oriented Recovery Enhancement sessions and one motivational interviewing session and nicotine replacement therapy.

OTHER

MORE and No MI and NRT

Eight group Mindfulness Oriented Recovery Enhancement sessions and nicotine replacement therapy.

OTHER

Support Group and MI and NRT

Eight group support group sessions and one motivational interviewing session and nicotine replacement therapy.

OTHER

Support Group and No MI and NRT

Eight group support group sessions and and nicotine replacement therapy.

Primary outcome measures

Days of Drug Use

Time frame: Baseline through 52 weeks.

Number of days of drug use as measured by self-reported days of use and biochemically verified use via drug screen.

Days of Tobacco Use

Time frame: Baseline through 52 weeks.

Number of days of tobacco use as measured by self-reported days of use and biochemically verified use via expired carbon monoxide.

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • English-speaking
  • Currently on methadone; and 4) currently smoke cigarettes.

Exclusion criteria

  • Severe cognitive impairment (score \>23 on Mini Mental Status Exam) or psychosis (positive SCID Psychotic Screen)
  • Suicidal risk (score ≥7 on Suicidal Behaviors Questionnaire)
  • Inability to attend or fully participate in intervention sessions or assessments
  • Previous formal mindfulness training (e.g., MBSR, MBRP) or MORE (from the R21 or R33
  • Currently taking smoking cessation pharmacotherapy or participating in smoking cessation counseling
  • Any contraindications for NRT
  • Currently or soon planning to be pregnant or breastfeeding.

Where

  • New Brunswick, New Jersey
  • Salt Lake City, Utah

Collaborators

University of Utah, National Institute on Drug Abuse (NIDA)

Related conditions & keywords

Polysubstance AbuseOpioid UseTobacco Use

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Apr 28, 2026 · Source of record for eligibility and locations

📊
1 of 420 participants interested
0% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

New Brunswick

New Jersey

Location available
RECRUITING

Salt Lake City

Utah

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More Multiple Myeloma Trials by City

Browse all multiple myeloma clinical trials in these cities — not just this study.

Looking for I cannot determine the primary medical condition from this data. The study title mentions "Recovery Enhancement" which suggests addiction or substance use, but the conditions listed are coded as intervention groups rather than medical conditions, and the brief summary is incomplete. Without clear condition information, I cannot provide a patient-facing medical condition. Treatment in New Brunswick?

Join others in New Jersey exploring innovative treatment options through clinical research

I cannot determine the primary medical condition from this data. The study title mentions "Recovery Enhancement" which suggests addiction or substance use, but the conditions listed are coded as intervention groups rather than medical conditions, and the brief summary is incomplete. Without clear condition information, I cannot provide a patient-facing medical condition. Treatment Options in New Brunswick, New Jersey

If you're searching for I cannot determine the primary medical condition from this data. The study title mentions "Recovery Enhancement" which suggests addiction or substance use, but the conditions listed are coded as intervention groups rather than medical conditions, and the brief summary is incomplete. Without clear condition information, I cannot provide a patient-facing medical condition. treatment in New Brunswick, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in New Brunswick, Salt Lake City and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with I cannot determine the primary medical condition from this data. The study title mentions "Recovery Enhancement" which suggests addiction or substance use, but the conditions listed are coded as intervention groups rather than medical conditions, and the brief summary is incomplete. Without clear condition information, I cannot provide a patient-facing medical condition.. All study-related care is provided at no cost to participants.

Local Sites
2 locations in New Jersey
Now Enrolling
Up to 420 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for I cannot determine the primary medical condition from this data. The study title mentions "Recovery Enhancement" which suggests addiction or substance use, but the conditions listed are coded as intervention groups rather than medical conditions, and the brief summary is incomplete. Without clear condition information, I cannot provide a patient-facing medical condition.?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for I cannot determine the primary medical condition from this data. The study title mentions "Recovery Enhancement" which suggests addiction or substance use, but the conditions listed are coded as intervention groups rather than medical conditions, and the brief summary is incomplete. Without clear condition information, I cannot provide a patient-facing medical condition.

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This I cannot determine the primary medical condition from this data. The study title mentions "Recovery Enhancement" which suggests addiction or substance use, but the conditions listed are coded as intervention groups rather than medical conditions, and the brief summary is incomplete. Without clear condition information, I cannot provide a patient-facing medical condition. Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT06033599. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.